Skip Navigation


Human Molecular Genetics Advance Access originally published online on July 14, 2004
Human Molecular Genetics 2004 13(18):1999-2010; doi:10.1093/hmg/ddh212
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/18/1999    most recent
ddh212v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ho, M.
Right arrow Articles by Brown, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, M.
Right arrow Articles by Brown, R. H., Jr
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol. 13, No. 18 © Oxford University Press 2004; all rights reserved

Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency

Mengfatt Ho1,*, Cristina M. Post2, Leah R. Donahue2, Hart G.W. Lidov3, Roderick T. Bronson4, Holly Goolsby5, Simon C. Watkins6, Gregory A. Cox2 and Robert H. Brown, Jr1

1Day Laboratory for Neuromuscular Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA, 2The Jackson Laboratory, Bar Harbor, ME 04609, USA, 3Department of Pathology, Children's Hospital, Boston, MA 02115, USA, 4Department of Pathology, Harvard Medical School, Boston, MA 02115, USA, 5Department of Neuropathology, Massachusetts General Hospital, MA 02114, USA and 6Center for Biologic Imaging, University of Pittsburgh, PA 15261, USA

Received April 22, 2004; Revised June 28, 2004; Accepted July 4, 2004

Limb girdle muscular dystrophy type 2B and Miyoshi myopathy are clinically distinct forms of muscular dystrophy that arise from defects in the dysferlin gene. Here, we report two novel lines of dysferlin-deficient mice obtained by (a) gene targeting and (b) identification of an inbred strain, A/J, bearing a retrotransposon insertion in the dysferlin gene. The mutations in these mice were located at the 3' and 5' ends of the dysferlin gene. Both lines of mice lacked dysferlin and developed a progressive muscular dystrophy with histopathological and ultrastructural features that closely resemble the human disease. Vital staining with Evans blue dye revealed loss of sarcolemmal integrity in both lines of mice, similar to that seen in mdx and caveolin-3 deficient mice. However, in contrast to the latter group of animals, the dysferlin-deficient mice have an intact dystrophin glycoprotein complex and normal levels of caveolin-3. Our findings indicate that muscle membrane disruption and myofiber degeneration in dysferlinopathy were directly mediated by the loss of dysferlin via a new pathogenic mechanism in muscular dystrophies. We also show that the mutation in the A/J mice arose between the late 1970s and the early 1980s, and had become fixed in the production breeding stocks. Therefore, all studies involving the A/J mice or mice derived from A/J, including recombinant inbred, recombinant congenic and chromosome substitution strains, should take into account the dysferlin defect in these strains. These new dysferlin-deficient mice should be useful for elucidating the pathogenic pathway in dysferlinopathy and for developing therapeutic strategies.

* To whom correspondence should be addressed at: Division of Medical Sciences, National Cancer Centre, 11 Hospital Drive, Singapore 169610. Tel: +65 62221920; Fax: +65 63720161; Email: dmshmf{at}nccs.com.sg


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
E. Fujita, Y. Kouroku, A. Isoai, H. Kumagai, A. Misutani, C. Matsuda, Y. K. Hayashi, and T. Momoi
Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II)
Hum. Mol. Genet., March 15, 2007; 16(6): 618 - 629.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
N. L. Washington and S. Ward
FER-1 regulates Ca2+-mediated membrane fusion during C. elegans spermatogenesis
J. Cell Sci., June 15, 2006; 119(12): 2552 - 2562.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. B. Sher, C. Aoyama, K. A. Huebsch, S. Ji, J. Kerner, Y. Yang, W. N. Frankel, C. L. Hoppel, P. A. Wood, D. E. Vance, et al.
A Rostrocaudal Muscular Dystrophy Caused by a Defect in Choline Kinase Beta, the First Enzyme in Phosphatidylcholine Biosynthesis
J. Biol. Chem., February 24, 2006; 281(8): 4938 - 4948.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
K. R. Doherty, A. Cave, D. B. Davis, A. J. Delmonte, A. Posey, J. U. Earley, M. Hadhazy, and E. M. McNally
Normal myoblast fusion requires myoferlin
Development, December 15, 2005; 132(24): 5565 - 5575.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Wenzel, J. Zabojszcza, M. Carl, S. Taubert, A. Lass, C. L. Harris, M. Ho, H. Schulz, O. Hummel, N. Hubner, et al.
Increased Susceptibility to Complement Attack due to Down-Regulation of Decay-Accelerating Factor/CD55 in Dysferlin-Deficient Muscular Dystrophy
J. Immunol., November 1, 2005; 175(9): 6219 - 6225.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.